Snapshot Study on Patients With Heart Failure

Global Registries And Surveys Programme - Heart Failure Snapshot Study (GRASP-HF)

Status

Enrolling by invitation

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06469814

Acronym

GRASP-HF

Enrollment

4000

Registered

2024-06-24

Start date

2024-09-27

Completion date

2029-07-01

Last updated

2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure

Brief summary

The goal of this observational study is to provide a better understanding of medical practice for heart failure management based on real-world data, collected both across Europe and the rest of the world, using robust methodology and representativeness within each country. Standard management of patients will be the diagnostic and therapeutic interventions routinely performed in each center for patients presenting with signs and symptoms of chronic/acute heart failure.

Detailed description

Information collected by the GRASP-HF study assesses adherence to the ESC HF Guidelines focusing on Quality Indicators, in both chronic and acute HF. For that reason, the GRASP-HF snapshot study is evolving in parallel with the long-term Heart Failure Association initiative - ICARe-HF: the Improving Care through Accreditation and Recognition in Heart Failure (ICARe-HF) programme. ICARe-HF is an international accreditation programme for heart failure centres which is about improving patient outcomes by raising standards in care facilities and recognising those that apply best practices. The GRASP-HF snapshot study serves to verify the performance of individual centres through data collection of real-world patient data.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Adult patients with chronic or acute Heart Failure (HF), regardless of ejection fraction, either: • Outpatient with chronic HF (including first-time diagnosis), according to the clinical judgment. OR • Patients admitted to hospital or presenting to Emergency Department or Acute out-patient care for acute HF for whom an IV (diuretics, inotropes, vasodilators) or mechanical therapy for HF (mechanical circulatory support) is administered.

Exclusion criteria

* Age \<18 years * Patients unwilling to consent (or patient's legally authorized representative unwilling to consent, if the patient is unable to consent).

Design outcomes

Primary

Measure	Time frame	Description
Adherence to ESC Guidelines in Heart Failure 2021	12 months per site	Full adherence to guidelines for heart failure management

Countries

Armenia, Austria, Azerbaijan, Belgium, Bhutan, Bosnia and Herzegovina, Bulgaria, Croatia, Cyprus, Czechia, United Arab Emirates

Contacts

STUDY_CHAIROvidiu Chioncel

Institute for Cardiovascular Diseases C.C. Iliescu, Bucaresti, Romania

Outcome results